ELENZA
Roanoke, Virginia, United States
About ELENZA
ELENZA, Inc. is developing the world's first electronic "AutoFocal" Intraocular Lens to compete in the multi-billion dollar IOL market. Elenza's highly proprietary next generation Accommodating IOL is designed to give patients a complete visual range, providing effective near, intermediate and distance vision. These electro-active IOLs use a proprietary combination of liquid-crystal chemistry, electricity, and integrated-circuitry to create smart optics, which will provide patients with the ability to see more naturally and clearly over the full range of vision. The technology includes an electro-active switchable element that automatically adjusts focusing power electronically, in milliseconds, to maintain constant in-focus vision for various working needs and/or light environments. The lens is controlled by a micro-sized power-cell with an expected 50+ year rechargeable cycle life.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $33.8M
- Last round: Series Unknown (Jul 2013)
- Website: elenza.com
- Phone: +1 5409899135
Industries & Categories
Health Care, Health Diagnostics, Medical Device
Canonical: https://fsome.com/organization/elenza-2544991 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.